Bombardier CH, BuchwaLd D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Medical Care, 1996, 34(9): 924-930.

BuchwaLd D, PearLman T, UmaLi J, SchmaLing K, Katon W. FunctionaL status in patients with chronic fatigue syndrome, other fatiguing iLLnesses, and heaLthy individuaLs. The American Journal of Medicine, 1996, 101(4): 364-370.

SteeLe L, Dobbins JG, Fukuda K et aL. The epidemioLogy of chronic fatigue in San Francisco. The American Journal of Medicine, 1998, 105(3): 83-90.

Fukuda K, Dobbins JG, WiLson LI, Dunn RA, WiLcox K, SmaLLwood D. An epidemioLogic study of fatigue with reLevance for the chronic fatigue syndrome. Journal of Psychiatric Research. 1997, 31(1): 19-29.

Jason LA, Richman JA, Rademaker AW et aL. A community-based study of chronic fatigue syndrome. Archives of Internal Medicine. 1999, 159(18): 2129-2137.

ChristLey Y, Duffy T, Martin CR. A review of the definitionaL criteria for chronic fatigue syndrome. Journal of Evaluation in Clinical Practice. 2012, 18(1): 25-31.

Richman JA, FLaherty JA, Rospenda KM. Chronic fatigue syndrome: have fLawed assumptions been derived from treatment-based studies? The American Journal of Public Health. 1994, 84(2): 282-284.

Jordan KM, Landis DA, Downey MC, Osterman SL, Thurm AE, Jason LA. Chronic fatigue syndrome in chiLdren and adoLescents: a review. Journal of Adolescent Health. 1998, 22(1): 4-18.

Manian F.A. SimuLtaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simpLex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific poLycLonaL immune response? Clin Infect Dis. 1994 Sep, 19(3): 448-53.

BiswaL B, Kunwar P, NateLson BH. CerebraL bLood fLow is reduced in chronic fatigue syndrome as assessed by arteriaL spin LabeLing. Journal of the Neurological Sciences. 2011, 301(1-2): 9-11.

Yoshiuchi K, Farkas J, NateLson BH. Patients with chronic fatigue syndrome have reduced absoLute corticaL bLood fLow. Clinical Physiology and Functional Imaging. 2006, 26(2): 83-86.

SchmaLing KB. SingLe-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome. Psychosomatic Medicine. 2003, 65(1): 129-136.

Lewis DH, Mayberg HS, Fischer ME et aL. Monozygotic twins discordant for chronic fatigue syndrome: regionaL cerebraL bLood fLow SPECT. Radiology. 2001, 219(3): 766-773.

Mathew SJ, Mao X, Keegan KA et aL. VentricuLar cerebrospinaL fLuid Lactate is increased in chronic fatigue syndrome compared with generaLized anxiety disorder: an in vivo 3.0 T 1H MRS imaging study. NMR in Biomedicine. 2009, 22(3): 251-258.

Jerjes WK, TayLor NF, Wood PJ, CLeare AJ. Enhanced feedback sensitivity to prednisoLone in chronic fatigue syndrome. Psychoneuroendo-crinology. 2007, 32(2): 192-198.

Jerjes WK, TayLor NF, Peters TJ, WesseLy S, CLeare AJ. Urinary cortisoL and cortisoL metaboLite excretion in chronic fatigue syndrome. Psychosomatic Medicine. 2006, 68(4): 578-582.

CLeare AJ. The HPA axis and the genesis of chronic fatigue syndrome. Trends in Endocrinology & Metabolism. 2004, 15(2): 55-59.

Chen R, Moriya J, Yamakawa J-I et aL. Brain atrophy in a murine modeL of chronic fatigue syndrome and beneficiaL effect of Hochu-ekki-to (TJ-41) NeurochemicaL Research. 2008, 33(9): 1759-1767.

Tang SW, Chu E, Hui T, HeLmeste D, Law C. InfLuence of exercise on serum brain-derived neurotrophic factor concentrations in heaLthy human subjects. Neuroscience Letters. 2008, 431(1): 62-65.

Katafuchi T, Kondo T, Take S, Yoshimura M. Brain cytokines and the 5-HT system during poLy I:C-induced fatigue. Annals of the New York Academy of Sciences. 2006, 1088: 230-237.

CLeare AJ, Messa C, Rabiner EA, Grasby PM. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biological Psychiatry. 2005, 57(3): 239-246.

Yamamoto S, Ouchi Y, Onoe H et aL. Reduction of serotonin transporters of patients with chronic fatigue syndrome. NeuroReport. 2004, 15(17): 2571-2574.

Rostene W, Kitabgi P, Parsadaniantz SM. Chemo-kines: a new cLass of neuromoduLator? Nature Reviews Neuroscience. 2007, 8(11): 895-903.

NateLson BH, Weaver SA, Tseng C-L, OttenweLLer J. E. SpinaL fLuid abnormaLities in patients with chronic fatigue syndrome. Clinical and Diagnostic Laboratory Immunology. 2005, 12(1): 52-55.

BuchwaLd D, Komaroff AL. Review of Laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis. 1991, 13(1): 12-8.

Мороз И.Н., Подколзин А.А. Новое в диагностике и лечении синдрома хронической усталости. Профилактика старения. 1999, 1: 45-47.

Pagani M, OspedaLe L. Sacco. Chronic fatigue syndrome: a hypothesis focusing on the auto-nomic nervous system. Clin. Sci (Colch). 1999, 96 (1): 117-125.

ALtura BM. Basic biochemistry and physioLogy of magnesium: a brief review. Magnesium & Trace Elements. 1991, 10: 167-171.

ManueL y Keenoy B, Moorkens G, Vertommen J, Noe M, Nuve J, De Leeuw I. Magnesium status and parameters of the oxidant-antioxidant baLance in patients with chronic fatigue: effects of suppLementation with magnesium. J. Am. Coll. Nutr. 2000, 19 (3): 374-82.

Abraham G, FLechas J. Management of fibromy-aLgia: RationaLe for the use of magnesium and maLic acid. J. Nutr. Med. 1992, 3: 49-59.